Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

ANTI-MULLERIAN HORMONE (AMH) - ANVISA Registration 80537410141

Access comprehensive regulatory information for ANTI-MULLERIAN HORMONE (AMH) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80537410141 and manufactured by GUANGZHOU WONDFO BIOTECH CO. LTD. The registration is held by CELER BIOTECNOLOGIA S/A with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including ROCHE DIAGNOSTICS GMBH, IMMUNOTECH, A BECKMAN COULTER COMPANY, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
80537410141
Registration Details
ANVISA Registration Number: 80537410141
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

CELER FINECARE AMH TESTE QUANTITATIVO
Risk Class II

Registration Details

80537410141

25351084159202586

04846613000103

Company Information

China
PT: CHINA, REPÚBLICA POPULAR

Dates and Status

Jun 30, 2025

VIGENTE

09/18/2025 19:00:01